Bradykinin is a potent pruritogen in atopic dermatitis: A switch from pain to itch

Pain

Volumn 126, Issue 1-3, 2006, Pages 16-23

  Hosogi, Miwa ^a   Schmelz, Martin ^b   Miyachi, Yoshiki ^a   Ikoma, Akihiko ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Histamine; Nociception; Pruritus; Sensitization

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIPRURITIC AGENT; BRADYKININ; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; OLOPATADINE; PLACEBO; SEROTONIN; SUBSTANCE P;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; IONTOPHORESIS; MALE; NOCICEPTION; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKIN DEFECT; SKIN PRURITUS; SKIN SENSITIZATION; SKIN TEST;

ADULT; BRADYKININ; CROSS-OVER STUDIES; DERMATITIS, ATOPIC; FEMALE; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; IONTOPHORESIS; MALE; PAIN; PRURITUS; SEROTONIN; SINGLE-BLIND METHOD; SUBSTANCE P; URTICARIA; WATER;

EID: 33751016799     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2006.06.003     Document Type: Article

References (42)

1. Andoh T., Nagasawa T., Satoh M., and Kuraishi Y. Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice. J Pharmacol Exp Ther 286 (1998) 1140-1145
2. Andrew D., and Craig A.D. Spinothalamic lamina 1 neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci 4 (2001) 72-77
3. Atanassoff P.G., Brull S.J., Zhang J., Greenquist K., Silverman D.G., and LaMotte R.H. Enhancement of experimental pruritus and mechanically evoked dysesthesiae with local anesthesia. Somatosens Mot Res 16 (1999) 291-298
4. Brown H., Moppett I.K., and Mahajan R.P. Transient hyperaemic response to assess vascular reactivity of skin: effect of locally iontophoresed acetylcholine, bradykinin, epinephrine and phenylephrine. Br J Anaesth 90 (2003) 446-451
5. Brull S.J., Atanassoff P.G., Silverman D.G., Zhang J., and LaMotte R.H. Attenuation of experimental pruritus and mechanically evoked dysesthesiae in an area of cutaneous allodynia. Somatosens Mot Res 16 (1999) 299-303
6. Church M.K. Non-H1-receptor effects of antihistamines. Clin Exp Allergy 29 (1999) 39-48
7. Dray A., and Perkins M. Bradykinin and inflammatory pain. Trends Neurosci 16 (1993) 99-104
8. Dumitrascu D. Mast cells as potent inflammatory cells. Rom J Intern Med 34 (1996) 159-172
9. Giannetti A., and Girolomoni G. Skin reactivity to neuropeptides in atopic dermatitis. Br J Dermatol 121 (1989) 681-688
10. Greaves M. Mast cell mediators other than histamine induced pruritus in atopic dermatitis patients - a dermal microdialysis study. Br J Dermatol 142 (2000) 1079-1080
11. Grewe M., Vogelsang K., Ruzicka T., Stege H., and Krutmann J. Neurotrophin-4 production by human epidermal keratinocytes: increased expression in atopic dermatitis. J Invest Dermatol 114 (2000) 1108-1112
12. Hagermark O. Peripheral and central mediators of itch. Skin Pharmacol 5 (1992) 1-8
13. Hagermark O. Studies on experimental itch induced by kallikrein and bradykinin. Acta Derm Venereol 54 (1974) 397-400
14. Hagermark O. Influence of antihistamines, sedatives, and aspirin on experimental itch. Acta Derm Venereol 53 (1973) 363-368
15. Hanifin J.M., and Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 92 (1980) 44-47
16. Hargreaves K.M., and Costello A. Glucocorticoids suppress levels of immunoreactive bradykinin in inflamed tissue as evaluated by microdialysis probes. Clin Pharmacol Ther 48 (1990) 168-178
17. Heyer G., Hornstein O.P., and Handwerker H.O. Skin reactions and itch sensation induced by epicutaneous histamine application in atopic dermatitis and controls. J Invest Dermatol 93 (1989) 492-496
18. Ikoma A., Rukwied R., Stander S., Steinhoff M., Miyachi Y., and Schmelz M. Neuronal sensitization for histamine-induced itch in lesional skin of patients with atopic dermatitis. Arch Dermatol 139 (2003) 1455-1458
19. Ikoma A., Fartasch M., Heyer G., Miyachi Y., Handwerker H., and Schmelz M. Painful stimuli evoke itch in patients with chronic pruritus: central sensitization for itch. Neurology 62 (2004) 212-217
20. Ikoma A., Handwerker H., Miyachi Y., and Schmelz M. Electrically evoked itch in humans. Pain 113 (2005) 148-154
21. Kinkelin I., Motzing S., Koltenzenburg M., and Brocker E.B. Increase in NGF content and nerve fiber sprouting in human allergic contact eczema. Cell Tissue Res 302 (2000) 31-37
22. Koppert W., Reeh P.W., and Handwerker H.O. Conditioning of histamine by bradykinin alters responses of rat nociceptor and human itch sensation. Neurosci Lett 152 (1993) 117-120
23. Kuraishi Y., Nagasawa T., Hayashi K., and Satoh M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur J Pharmacol 275 (1995) 229-233
24. Leung D.Y.M. Molecular basis of allergic diseases. Mol Genet Metab 63 (1998) 157-167
25. Leurs R., Church M.K., and Taglialatela M. H1-antishitamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy 32 (2002) 489-498
26. Newton D.J., Khan F., and Belch J.J. Assessment of microvascular endothelial function in human skin. Clin Sci (Lond) 101 (2001) 567-572
27. Nojima H., Simons C.T., Cuellar J.M., Carstens M.I., Moore J.A., and Carstens E. Opioid modulation of scratching and spinal c-fos expression evoked by intradermal serotonin. J Neurosci 23 (2003) 10784-10790
28. Ohmura T., Hayashi T., Satoh Y., Konomi A., Jung B., and Satoh H. Involvement of substance P in scratching behaviour in an atopic dermatitis model. Eur J Pharmacol 491 (2004) 191-194
29. Schmelz M., Schmidt R., Bickel A., Handwerker H.O., and Torebjork H.E. Specific C-receptors for itch in human skin. J Neurosci 17 (1997) 8003-8008
30. Schmelz M., Hilliges M., Schmidt R., Orstavik K., Vahlquist C., Weidner C., et al. Active "itch fibers" in chronic pruritus. Neurology 61 (2003) 564-566
31. Schmelz M., Schmidt R., Weidner C., Hilliges M., Torebjork H.E., and Handwerker H.O. Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J Neurophysiol 89 (2003) 2441-2448
32. Shu X.Q., and Mendell L.M. Neurotrophins and hyperalgesia. Proc Natl Acad Sci USA 96 (1999) 7693-7696
33. Simone D.A., Alreja M., and LaMotte R.H. Psychophysical studies of the itch sensation and itchy skin ("alloknesis") produced by intracutaneous injection of histamine. Somatosens Mot Res 8 (1991) 271-279
34. Stahle-Backdahl M., Hagermark O., and Lins L.E. The sensitivity of uremic and normal human skin to histamine. Acta Derm Venereol 68 (1988) 230-235
35. Thomsen J.S., Sonne M., Benfeldt E., Jensen S.B., Serup J., and Menne T. Experimental itch in sodium lauryl sulphate-inflamed and normal skin in humans: a randomized, double-blind, placebo-controlled study of histamine and other inducers of itch. Br J Dermatol 146 (2002) 792-800
36. Toyoda M., Nakamura M., Makino T., Hino T., Kagoura M., and Morohashi M. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 147 (2002) 71-79
37. Treede R.D., and Magerl W. Multiple mechanisms of secondary hyperalgesia. Prog Brain Res 129 (2000) 331-341
38. Uehara M. Reduced histamine reaction in atopic dermatitis. Arch Dermatol 118 (1982) 244-245
39. Urashima R., and Mihara M. Cutaneous nerves in atopic dermatitis - a histological, immunohistochemical and electron microscopic study. Virchows Arch Int J Pathol 432 (1998) 363-370
40. Weidner C., Klede M., Rukwied R., et al. Acute effects of substance P and calcitonin gene-related peptide in human skin - a microdialysis study. J Invest Dermatol 115 (2000) 1015-1020
41. Weisshaar E., Ziethen B., and Gollnick H. Can a serotonin type 3 (5-HT3) receptor antagonist reduce experimentally-induced itch?. Inflamm Res 46 (1997) 412-416
42. Yosipovitch G., Fast K., and Bernhard J.D. Noxious heat and scratching decrease histamine-induced itch and skin blood flow. J Invest Dermatol 125 (2005) 1268-1272